Sylwia Pieniek-Szelag
Szczecin, ZP 70111, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The Impact of UGT1A1 Genetic Variability on Enzyme Expression in Liver Pathology.
Journal: Genes
Published: April 01, 2026
The involvement of miRNAs in CYP450 enzymes and UDP-glucuronosyltransferases regulation in the human liver.
Journal: Scientific reports
Published: January 25, 2026
Protein Abundance of Drug Metabolizing Enzymes in Human Hepatitis C Livers.
Journal: International journal of molecular sciences
Published: December 22, 2022
Protein Abundance of Drug Transporters in Human Hepatitis C Livers.
Journal: International journal of molecular sciences
Published: June 25, 2022
The reference liver-CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype.
Journal: Pharmacological reports : PR
Published: August 30, 2021
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology.
Journal: Pharmaceutics
Published: July 13, 2021
Hepatic drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failure.
Journal: Pharmacological reports : PR
Published: February 09, 2021
Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases.
Journal: International journal of molecular sciences
Published: August 04, 2020
Monocarboxylate Transporter 1 (MCT1) in Liver Pathology.
Journal: International journal of molecular sciences
Published: February 08, 2020
Protein Abundance of Hepatic Drug Transporters in Patients With Different Forms of Liver Damage.
Journal: Clinical pharmacology and therapeutics
Published: March 11, 2019
The reference liver - ABC and SLC drug transporters in healthy donor and metastatic livers.
Journal: Pharmacological reports : PR
Published: January 02, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026